Sort
21,453 grants matching “tuberculosis”
TUBERCULOSIS ELIMINATION AND LABORATORY COOPERATIVE AGREEMENT
$1,327,578Laura Reeves · Florida State Department Of Health · U52 · FY2016 · PS
TUBERCULOSIS ELIMINATION AND LABORATORY COOPERATIVE AGREEMENT, ILLINOIS OUTSIDE O
$1,327,182Joe Ramos · Illinois State Dept Of Public Health · U52 · FY2011 · PS
Observational Antiretroviral Studies In Southern Africa (OASIS) Collaboration
$1,326,850Matthias Egger · Universitat Bern · U01 · FY2007 · AI
The International URBAN Alcohol Research Collaboration on HIV/AIDS (ARCH) Center
$1,325,994Jeffrey H Samet · Boston Medical Center · P01 · FY2022 · AA
Accuracy of the Xpert Ultra for Diagnosis of Pulmonary Tuberculosis
$1,325,755Susan E Dorman · Medical University Of South Carolina · R01 · FY2018 · AI
Optimizing Multi-drug Mycobacterium tuberculosis Therapy for Rapid Sterilization and Resistance Suppression
$1,324,774Arnold Louie · University Of Florida · R01 · FY2025 · AI
ADULT THERAPEUTIC CLINICAL TRIALS PROGRAM IN AIDS
$1,323,311Donna Mildvan · Beth Israel Medical Ctr (New York) · U01 · FY2006 · AI
TUBERCULOSIS CONTROL PROGRAM AND AIDS
$1,321,426Jim Scioneaux · Louisiana State Office Of Public Health · U52 · FY2007 · PS
TUBERCULOSIS SURVEILLANCE, PREVENTION AND CONTROL/ELIMINATION COOPERATIVE AGREEME
$1,321,133James Scioneaux · Louisiana State Office Of Public Health · U52 · FY2011 · PS
Epigenetic & Post-Translational Mechanisms of Macrophage Resistance to Mycobacterium tuberculosis During HIV Co-Infection
$1,319,833Thomas R Hawn · University Of Washington · R33 · FY2021 · AI
Aurum Clinical Trials Unit
$1,319,570Gavin John Churchyard · Aurum Institute Npc · UM1 · FY2023 · AI
Disseminated Tuberculosis in HIV Infection
$1,317,869C. Fordham Von Reyn · Dartmouth College · U01 · FY2006 · AI
Immunotherapy to prevent drug-resistant tuberculosis
$1,315,804Rhea N Coler · Access To Advanced Health Institute · R01 · FY2016 · AI
Stellenbosch University Clinical Trials Unit
$1,315,748Anneke Catharina Hesseling · Stellenbosch University · UM1 · FY2024 · AI
Philadelphia HIV Therapeutics and Prevention Clinical Trials Unit
$1,315,740Pablo Tebas · University Of Pennsylvania · UM1 · FY2015 · AI
Phase 2 Pharmacodynamic Study of High-dose Levofloxacin in MDR-TB Treatment
$1,314,777C Robert Horsburgh · Boston University Medical Campus · U01 · FY2015 · AI
Preclinical Development Services for AIDS Therapeutics: Pharmacology and Toxicology
$1,314,501Jon Mirsalis · Sri International · N01 · FY2020 · AI
Optimizing Multi-drug Mycobacterium tuberculosis Therapy for Rapid Sterilization and Resistance Suppression
$1,314,301George Louis Drusano · University Of Florida · R01 · FY2023 · AI
Immunotherapy to prevent drug-resistant tuberculosis
$1,314,028Rhea N Coler · Access To Advanced Health Institute · R01 · FY2017 · AI
Disseminated Tuberculosis in HIV Infection
$1,313,181C. Fordham Von Reyn · Dartmouth College · U01 · FY2007 · AI
TUBERCULOSIS ELIMINATION AND LABORATORY COOPERATIVE AGREEMENTS
$1,309,057Shea S Rabley · South Carolina Department Of Public Health · U52 · FY2011 · PS
Experimental Animal Models of TB: Chemotherapeutics and Imaging
$1,306,989Clifton Barry · National Institute Of Allergy And Infectious Diseases · ZIA · FY2016 · AI
Natural History of HIV Infection in Injection Drug Users
$1,306,165Johns Hopkins University · R37 · FY2004 · DA
Immunopathogenic Mechanisms of Human Immunodeficiency Virus (HIV) Disease
$1,304,892Irini Sereti · National Institute Of Allergy And Infectious Diseases · ZIA · FY2014 · AI
JOHNS HOPKINS ADULT AIDS CLINICAL TRIALS UNIT
$1,304,490Johns Hopkins University · U01 · FY2000 · AI